<DOC>
	<DOC>NCT01446601</DOC>
	<brief_summary>The purpose of this study is to evaluate the benefits and risks of hypoglossal nerve stimulation with the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System as a potential therapeutic option for individuals with moderate to severe Obstructive Sleep Apnea (OSA) that have failed or do not tolerate positive airway pressure (PAP) therapy.</brief_summary>
	<brief_title>Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Age 21 to 80 years Body mass index (BMI) ≤ 35 kg/m² Previously diagnosed with Moderate to severe OSA Individual has failed or does not tolerate PAP therapy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Apnea</keyword>
	<keyword>OSA</keyword>
	<keyword>Sleep Apnea Syndromes</keyword>
	<keyword>Sleep Apnea, Obstructive</keyword>
	<keyword>Hypoglossal Nerve Stimulation</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Tongue</keyword>
</DOC>